Macarena C. Cáceres

753 total citations
31 papers, 519 citations indexed

About

Macarena C. Cáceres is a scholar working on Pharmacology, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Macarena C. Cáceres has authored 31 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Oncology and 8 papers in Psychiatry and Mental health. Recurrent topics in Macarena C. Cáceres's work include Pharmacogenetics and Drug Metabolism (11 papers), Cancer-related cognitive impairment studies (5 papers) and Schizophrenia research and treatment (4 papers). Macarena C. Cáceres is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Cancer-related cognitive impairment studies (5 papers) and Schizophrenia research and treatment (4 papers). Macarena C. Cáceres collaborates with scholars based in Spain, Portugal and Hungary. Macarena C. Cáceres's co-authors include Adrián LLerena, Pedro Dorado, Roland Berecz, Eva Peñas‐Lledó, Alfredo de la Rubia, Eulalia Pozo‐Guisado, Julio Licínio, Ma‐Li Wong, I Degrell and Patricia Palomo‐López and has published in prestigious journals such as Scientific Reports, Journal of Affective Disorders and International Journal of Environmental Research and Public Health.

In The Last Decade

Macarena C. Cáceres

28 papers receiving 504 citations

Peers

Countries citing papers authored by Macarena C. Cáceres

Since Specialization

Citations

This map shows the geographic impact of Macarena C. Cáceres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Macarena C. Cáceres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Macarena C. Cáceres more than expected).

Fields of papers citing papers by Macarena C. Cáceres

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Macarena C. Cáceres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Macarena C. Cáceres. The network helps show where Macarena C. Cáceres may publish in the future.

Co-authorship network of co-authors of Macarena C. Cáceres

This figure shows the co-authorship network connecting the top 25 collaborators of Macarena C. Cáceres. A scholar is included among the top collaborators of Macarena C. Cáceres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Macarena C. Cáceres. Macarena C. Cáceres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of mental health status and clinical factors on health-related quality of life in patients undergoing haemodialysis: a multicentre cross-sectional study 2025 ·BMJ Open ·(unknown), (unknown), Jesús Montanero‐Fernández, (unknown), (unknown), Macarena C. Cáceres	0
2	Assessing Emotional Intelligence and Reducing Burnout in Nursing Students Through Simulation‐Based Learning Experiences: An Experimental Design 2025 ·International Journal of Mental Health Nursing ·(unknown), (unknown), Jesús Montanero‐Fernández, (unknown), (unknown), Macarena C. Cáceres	0
3	Prevalence of Psychoneurological Symptoms and Symptom Clusters in Women with Breast Cancer Undergoing Treatment: Influence on Quality of Life 2023 ·Seminars in Oncology Nursing ·(unknown), (unknown), (unknown), Jesús Montanero‐Fernández, Patricia Palomo‐López, Macarena C. Cáceres	5
4	Self-care nursing assessment: cross-cultural adaptation and validation of the Spanish version of the Self-care of chronic illness inventory 2023 ·BMC Nursing ·(unknown), (unknown), (unknown), Jesús Montanero‐Fernández, (unknown), Macarena C. Cáceres	2
5	Factors Related to Anxiety, Depressive Symptoms and Quality of Life in Breast Cancer 2022 ·International Journal of Environmental Research and Public Health ·Macarena C. Cáceres, (unknown), (unknown), (unknown), (unknown), (unknown)	19
6	Depressive Symptoms and Quality of Life Associated With the Use of Monoclonal Antibodies in Breast Cancer Treatment 2021 ·Oncology nursing forum ·Macarena C. Cáceres, (unknown), (unknown), (unknown), (unknown), (unknown)	4
7	<p>Understanding Resilience Factors Among Caregivers of People with Alzheimer’s Disease in Spain</p> 2020 ·Psychology Research and Behavior Management ·(unknown), (unknown), (unknown), (unknown), Patricia Palomo‐López, Macarena C. Cáceres	21
8	<p>The importance of early identification of infusion-related reactions to monoclonal antibodies</p> 2019 ·Therapeutics and Clinical Risk Management ·Macarena C. Cáceres, (unknown), (unknown), Patricia Palomo‐López, (unknown), (unknown)	27
9	Impact factor evolution of nursing research journals: 2009 to 2014 2017 ·Nursing Outlook ·Macarena C. Cáceres, (unknown), (unknown), (unknown), (unknown), (unknown)	9
10	Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers 2008 ·European Journal of Clinical Pharmacology ·Pedro Dorado, Isa Cavaco, Macarena C. Cáceres, (unknown), Vera Ribeiro, Adrián LLerena	23
11	Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5‐HTTLPR‐S) and the CYP2C93* allele 2007 ·Fundamental and Clinical Pharmacology ·Pedro Dorado, Eva Peñas‐Lledó, (unknown), Macarena C. Cáceres, J. Cobaleda, Adrián LLerena	29
12	Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients 2007 ·European Journal of Clinical Pharmacology ·Macarena C. Cáceres, Eva Peñas‐Lledó, Alfredo de la Rubia, Adrián LLerena	12
13	Low frequency of CYP2D6 poor metabolizers among schizophrenia patients 2007 ·The Pharmacogenomics Journal ·Adrián LLerena, Pedro Dorado, Eva Peñas‐Lledó, Macarena C. Cáceres, Alfredo de la Rubia	35
14	Association between T102C and A–1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs 2007 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Eva Peñas‐Lledó, Pedro Dorado, Macarena C. Cáceres, Alfredo de la Rubia, Adrián LLerena	22
15	Clinical Implications of CYP2D6 Genetic Polymorphism During Treatment with Antipsychotic Drugs 2006 ·Current Drug Targets ·Pedro Dorado, Roland Berecz, (unknown), Macarena C. Cáceres, Adrián LLerena	20
16	Reduced completed suicide rate in Hungary from 1990 to 2001: Relation to suicide methods 2005 ·Journal of Affective Disorders ·Roland Berecz, Macarena C. Cáceres, (unknown), Pedro Dorado, (unknown), Eva Peñas‐Lledó, Adrián LLerena, I Degrell	20
17	Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship 2005 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Pedro Dorado, Roland Berecz, Macarena C. Cáceres, (unknown), J. Cobaleda, Adrián LLerena	13
18	Analysis of diclofenac and its metabolites by high-performance liquid chromatography: relevance of CYP2C9 genotypes in diclofenac urinary metabolic ratios 2003 ·Journal of Chromatography B ·Pedro Dorado, Roland Berecz, Macarena C. Cáceres, Adrián LLerena	22
19	Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients 2002 ·Journal of Chromatography B ·Adrián LLerena, Pedro Dorado, Roland Berecz, Antonio González, (unknown), Alfredo de la Rubia, Macarena C. Cáceres	51
20	Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions 2002 ·Journal of Chromatography B ·Adrián LLerena, Roland Berecz, Pedro Dorado, (unknown), (unknown), Macarena C. Cáceres, (unknown)	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact